Your Messages Inbox
Your Article Summary
See Latest ArticlesFront line treatment of elderly multiple myeloma in the era of novel agents
Biologics: targets & therapy, 12/11/08
Venon MD et al. - Melphalan combined with prednisone (MP) has long been the historical treatment of reference for a large proportion of elderly myeloma (MM) patients ineligible for autologous stem cell transplantation, and is still the backbone of new regimens that include the new era of novel agents. Melphalan–prednisone–thalidomide (MPT) and melphalan-prednisone-bortezomib, proved superior to MP, currently appear to be the treatments of choice for this population.
Related Articles
Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study
Annals of Hematology, 11/25/09
Relevance Score: 90%
Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology, 11/20/09
Relevance Score: 88%
Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma
British Journal of Haematology, 11/20/09
Relevance Score: 88%
Salvage treatment with upfront melphalan 100 mg/m2 and consolidation with novel drugs for fulminant progression of multiple myeloma
Annals of Hematology, 11/25/09
Relevance Score: 87%
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
Core Evidence, 11/18/09
Relevance Score: 87%
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Major Study Finds Anti-HIV Gel Ineffective Among Women
National Institute of Allergy and Infectious Disease - News, 12/17/09
Trends in hypertension treatment in diabetes
Current Hypertension Reports, 12/09/09
New program helps educate survivors of a heart event about the importance of maintaining good physical and emotional health
Daiichi Sankyo, 12/08/09
Article Search
Sponsor